Salivary molecular spectroscopy: a sustainable, rapid and non-invasive monitoring tool for diabetes mellitus during insulin treatment
Accessed 18th March, 2026
For a comparison benchmark, proprietary GLP-1s by Novo or Lilly individually are expected to exceed such numbers, but Metsera offered a unique combination not held by Pfizer pre-acquisition
Custom Protocol Personalized treatment plan with precise dosing schedule, administration guidance, and integration with complementary longevity interventions
Surgical resection of lesions is a common treatment, but beyond accessibility issues in low-resource settings, it has limited efficacy, and rates of lesion recurrence, repetitive surgical procedures and pain persistence are high